New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication

被引:6
作者
Qin, Sha [1 ,2 ]
Xie, Bin [1 ]
Wang, Qingyi [1 ,2 ]
Yang, Rui [1 ,2 ]
Sun, Jingyue [1 ,2 ]
Hu, Chaotao [3 ]
Liu, Shuang [4 ]
Tao, Yongguang [1 ,5 ,6 ]
Xiao, Desheng [1 ,2 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Sch Basic Med Sci, Xiangya Sch Med, Dept Pathol, Changsha, Hunan, Peoples R China
[3] Univ Chinese Acad Sci, Med Sch, Regenerat Med, Beijing, Peoples R China
[4] China Univ, Cent South Univ, Xiangya Hosp, Dept Oncol,Inst Med Sci,Natl Clin Res Ctr Geriatr, Changsha, Hunan, Peoples R China
[5] Cent South Univ, Canc Res Inst, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China
[6] Cent South Univ, Sch Basic Med, Changsha, Hunan, Peoples R China
来源
MEDCOMM | 2024年 / 5卷 / 06期
基金
中国国家自然科学基金;
关键词
cancer immunotherapy; epigenetic modification; immune cells communication; metabolic modulation; REGULATORY T-CELLS; INFILTRATING LYMPHOCYTE THERAPY; TUMOR-ASSOCIATED MACROPHAGES; FDA APPROVAL; LUNG-CANCER; SUPPRESSOR-CELLS; DENDRITIC CELLS; PROGNOSTIC BIOMARKER; MURINE MODEL; CROSS-TALK;
D O I
10.1002/mco2.551
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cancer is one of the leading causes of death worldwide, and more effective ways of attacking cancer are being sought. Cancer immunotherapy is a new and effective therapeutic method after surgery, radiotherapy, chemotherapy, and targeted therapy. Cancer immunotherapy aims to kill tumor cells by stimulating or rebuilding the body's immune system, with specific efficiency and high safety. However, only few tumor patients respond to immunotherapy and due to the complex and variable characters of cancer immune escape, the behavior and regulatory mechanisms of immune cells need to be deeply explored from more dimensions. Epigenetic modifications, metabolic modulation, and cell-to-cell communication are key factors in immune cell adaptation and response to the complex tumor microenvironment. They collectively determine the state and function of immune cells through modulating gene expression, changing in energy and nutrient demands. In addition, immune cells engage in complex communication networks with other immune components, which are mediated by exosomes, cytokines, and chemokines, and are pivotal in shaping the tumor progression and therapeutic response. Understanding the interactions and combined effects of such multidimensions mechanisms in immune cell modulation is important for revealing the mechanisms of immunotherapy failure and developing new therapeutic targets and strategies. Relationships between immune cell metabolism, epigenetics modulation, and cancer immunotherapy clinical efficiency. Epigenetic regulation (including DNA methylation, RNA methylation, histone modification, and chromatin remodeling) of immune cells can influence the differentiation and activity of immune cells, while metabolic status influences the energy supply and reactivity of immune cells, and they are participated in cancer immunotherapy and influenced clinical effect through immune cells as a bridge. (Me, methylation; U, ubiquitination; Ac, acetylation; P, phosphorylation). image
引用
收藏
页数:32
相关论文
共 299 条
  • [21] EXTL3 could serve as a potential biomarker of prognosis and immunotherapy for prostate cancer and its potential mechanisms
    Chang, Pingan
    Chen, Shenglan
    Chang, Xiumei
    Zhu, Jiaxi
    Tang, Qingsheng
    Ma, Limin
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
  • [22] Immune signature of tumor-infiltrating immune cells predicts the prognosis and therapeutic effects in squamous cell carcinoma
    Che, Yun
    Luo, Zhiwen
    Zhang, Chaoqi
    Sun, Nan
    Gao, Shugeng
    He, Jie
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 87
  • [23] Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery
    Chen, Binfan
    Gao, Ang
    Tu, Bin
    Wang, Yonghui
    Yu, Xiaolu
    Wang, Yingshu
    Xiu, Yanfeng
    Wang, Bing
    Wan, Yakun
    Huang, Yongzhuo
    [J]. BIOMATERIALS, 2020, 255
  • [24] Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)
    Chen, Helen X.
    Song, Minkyung
    Maecker, Holden T.
    Gnjatic, Sacha
    Patton, David
    Lee, J. Jack
    Adam, Stacey J.
    Moravec, Radim
    Liu, Xiaole Shirley
    Cerami, Ethan
    Lindsay, James
    Tang, Ming
    Hodi, F. Stephen
    Wu, Catherine J.
    Wistuba, Ignacio I.
    Al-Atrash, Gheath
    Bernatchez, Chantale
    Bendall, Sean C.
    Hewitt, Stephen M.
    Sharon, Elad
    Streicher, Howard
    Enos, Rebecca A.
    Bowman, Melissa D.
    Tatard-Leitman, Valerie M.
    Sanchez-Espiridion, Beatriz
    Ranasinghe, Srinika
    Pichavant, Mina
    Del Valle, Diane M.
    Yu, Joyce
    Janssens, Sylvie
    Peterson-Klaus, Jenny
    Rowe, Cathy
    Bongers, Gerold
    Jenq, Robert R.
    Chang, Chia-Chi
    Abrams, Jeffrey S.
    Mooney, Margaret
    Doroshow, James H.
    Harris, Lyndsay N.
    Thurin, Magdalena
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (18) : 5038 - 5048
  • [25] CTNNB1 Alternation Is a Potential Biomarker for Immunotherapy Prognosis in Patients With Hepatocellular Carcinoma
    Chen, Lin
    Zhou, Qiaodan
    Liu, Junjie
    Zhang, Wei
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [26] Role of non-coding RNA in immune microenvironment and anticancer therapy of gastric cancer
    Chen, Liqiao
    Deng, Jingyu
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2022, 100 (12): : 1703 - 1719
  • [27] A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLC
    Chen, Mitchell
    Lu, Haonan
    Copley, Susan J.
    Han, Yidong
    Logan, Andrew
    Viola, Patrizia
    Cortellini, Alessio
    Pinato, David J.
    Power, Danielle
    Aboagye, Eric O.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (06) : 718 - 730
  • [28] Tumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1
    Chen, Sheng
    Cui, Wenyu
    Chi, Zhexu
    Xiao, Qian
    Hu, Tianyi
    Ye, Qizhen
    Zhu, Kaixiang
    Yu, Weiwei
    Wang, Zhen
    Yu, Chengxuan
    Pan, Xiang
    Dai, Siqi
    Yang, Qi
    Jin, Jiacheng
    Zhang, Jian
    Li, Mobai
    Yang, Dehang
    Yu, Qianzhou
    Wang, Quanquan
    Yu, Xiafei
    Yang, Wei
    Zhang, Xue
    Qian, Junbin
    Ding, Kefeng
    Wang, Di
    [J]. CELL METABOLISM, 2022, 34 (11) : 1843 - +
  • [29] HBO1 induces histone acetylation and is important for non-small cell lung cancer cell growth
    Chen, Teng-fei
    Hao, Hui-fei
    Zhang, Yan
    Chen, Xiao-yu
    Zhao, Hua-si
    Yang, Rui
    Li, Ping
    Qiu, Ling-xiao
    Sang, Yong-hua
    Xu, Chun
    Liu, Shao-xia
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (08): : 3313 - 3323
  • [30] Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment
    Chen, Yang
    Jia, Keren
    Sun, Yu
    Zhang, Cheng
    Li, Yilin
    Zhang, Li
    Chen, Zifan
    Zhang, Jiangdong
    Hu, Yajie
    Yuan, Jiajia
    Zhao, Xingwang
    Li, Yanyan
    Gong, Jifang
    Dong, Bin
    Zhang, Xiaotian
    Li, Jian
    Shen, Lin
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)